Cargando…
Update on management options in the treatment of nosocomial and ventilator assisted pneumonia: review of actual guidelines and economic aspects of therapy
OBJECTIVE: Nosocomial or more exactly, hospital-acquired (HAP) and ventilator-associated pneumonia (VAP) are frequent conditions when treating intensive care unit (ICU) patients that are only exceeded by central line-associated bloodstream infections. In Germany, approximately 18,900 patients per ye...
Autores principales: | Wilke, Michael, Grube, Rolf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872224/ https://www.ncbi.nlm.nih.gov/pubmed/24379684 http://dx.doi.org/10.2147/IDR.S25985 |
Ejemplares similares
-
Guideline-adherent initial intravenous antibiotic therapy for hospital-acquired/ventilator-associated pneumonia is clinically superior, saves lives and is cheaper than non guideline adherent therapy
por: Wilke, MH, et al.
Publicado: (2011) -
Current treatment of nosocomial pneumonia and ventilator-associated pneumonia
por: Plata-Menchaca, Erika P., et al.
Publicado: (2022) -
Update of the treatment of nosocomial pneumonia in the ICU
por: Zaragoza, Rafael, et al.
Publicado: (2020) -
Nosocomial Pneumonia in the Era of Multidrug-Resistance: Updates in Diagnosis and Management
por: Xu, Elena, et al.
Publicado: (2021) -
Impact of nosocomial pneumonia on the outcome of mechanically-ventilated patients
por: Violán, J Solé, et al.
Publicado: (1998)